Health
Latest News: Todays Latest News Headlines from India & World | Hindustan Times | Hindustan Times

KGMU patients head outside for medicines, as drugs elude subsidised stores

Source Entity

Latest News: Todays Latest News Headlines from India & World | Hindustan Times | Hindustan Times

September 2, 2026
KGMU patients head outside for medicines, as drugs elude subsidised stores

Patients at KGMU, Lucknow, are facing significant hardship as subsidised pharmacy stores frequently lack essential medicines. Families are being forced to purchase supplies from expensive private vendors, undermining the hospital's mandate for affordable care.

The Crisis of Affordability at KGMU

King George’s Medical University (KGMU) in Lucknow, one of India's premier medical institutions, is currently facing a critical operational challenge regarding its pharmacy services. Despite the existence of 28 Hospital Revolving Fund (HRF) stores designed to provide medicines at subsidized rates, patients and their families report a recurring inability to procure essential drugs and surgical items on-site. This failure forces vulnerable individuals to seek these items from private pharmacies outside the campus, often at significantly higher costs.

Impact on Regional Healthcare Access

The significance of this issue extends far beyond the hospital gates. KGMU serves as a primary referral center for patients traveling from across Uttar Pradesh and neighboring states. For many of these families, the affordability of treatment is the deciding factor in whether they can continue care. When the subsidized network fails, the financial burden shifts immediately onto the patient, threatening to derail the continuity of medical treatment for those already struggling with complex health conditions.

The Human Cost of Supply Chain Gaps

Individual cases highlight the human toll of these administrative failures. For instance, patients like Rubeena, a resident of Bahraich who was admitted to the Obstetrics and Gynaecology wing of Queen Mary’s Hospital for an ovarian cyst, rely heavily on the hospital's promise of accessible care. When such patients are directed to private markets for basic surgical supplies, it creates a barrier to treatment that can lead to delayed surgeries or financial distress, effectively nullifying the benefits of the government-subsidized healthcare model.

Systemic Challenges in Drug Procurement

The reliance on the HRF model implies a complex logistics and inventory management system that is clearly struggling to keep pace with patient demand. The inability to maintain a consistent stock of essential medicines suggests potential bottlenecks in procurement, distribution, or inventory forecasting. Without a robust supply chain, the promise of 'affordable treatment' remains a theoretical goal rather than a practical reality for the thousands of patients who depend on KGMU for life-saving interventions.

Broader Implications and Future Outlook

This situation underscores a broader trend in public health where infrastructure growth is not always matched by the necessary operational support for ancillary services like pharmacies. For KGMU to maintain its reputation and mandate, an urgent audit of the HRF system is necessary. Future trends suggest that if these gaps are not addressed, patient trust in public medical institutions may erode, forcing a shift toward more expensive private healthcare alternatives, which further exacerbates the economic disparity in access to medicine.

Conclusion

In summary, the current state of the pharmacy network at KGMU represents a significant disconnect between the institution's mission and the patient experience. Ensuring that subsidized medicines are consistently available is not merely an administrative task; it is a fundamental requirement for equitable healthcare delivery. Addressing these supply chain failures is essential to protecting the financial and physical well-being of the patients who rely on the hospital's services.